[Prescribing insulin in type 2 diabetes].
Insulintherapy is often the only way to obtain satisfactory glycaemic control in type 2 diabetic patients after several years of evolution of the disease. However, independently of the reluctance of the patient, it poses a few specific problems, and particularly that of weight gain initiating a vicious circle leading to deterioration of the metabolic control and to a progressive increase of insulin doses. Specific therapeutic protocols combining oral drugs and insulin have been promoted, but their efficacy is generally limited in course of time, and change to conventional or even intensified insulintherapy is in that case required. The practitioner will have to overcome his fear of using high insulin doses and give to therapeutic education the right place in order to guarantee the long term success of insulintherapy and so an effective prevention of diabetic complications.
Blicklé
Jean-Frédéric
JF
Service de médecine interne, diabétologie et maladies métaboliques Hôpitaux universitaires de Strasbourg Hôpital civil 67091 Strasbourg. Jean-Frederic.Blickle@chru-strasbourg.fr
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D018450:Disease Progression; D004334:Drug Administration Schedule; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007267:Injections; D007328:Insulin / Q000627:therapeutic use*; D010353:Patient Education as Topic
D000305:Adrenal Cortex Hormones; D007004:Hypoglycemic Agents; D007328:Insulin